Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)
China · Delayed Price · Currency is CNY 40.60
-0.53 (-1.29%)
At close: Jul 15, 2026
SHA:688163 Market Cap
SHA:688163 has a market cap or net worth of 4.45 billion as of July 15, 2026. Its market cap has increased by 111.36% in one year.
Market Cap
4.45B
Enterprise Value
3.69B
Revenue
197.68M
Ranking
n/a
PE Ratio
76.81
Stock Price
40.60
Market Cap Chart
Since March 11, 2022, SHA:688163's market cap has decreased from 5.98B to 4.45B, a decrease of -25.62%. That is a compound annual growth rate of -6.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 4.45B | 88.93% |
| Dec 31, 2025 | 2.36B | 23.97% |
| Dec 31, 2024 | 1.90B | -12.16% |
| Dec 29, 2023 | 2.16B | -5.22% |
| Dec 30, 2022 | 2.28B | -61.86% |
| Mar 11, 2022 | 5.98B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Suzhou Fengbei Biotech Stock | 4.61B |
| Wuhan Hvsen Biotechnology | 4.56B |
| ChemPartner PharmaTech | 4.46B |
| Hefei Lifeon Pharmaceutical | 4.28B |
| Kexing Biopharm | 4.24B |
| Shanghai Obio Technology (Group) Corp. | 4.23B |
| Jiangsu Sihuan Bioengineering | 4.18B |
| Anhui Huaheng Biotechnology | 4.09B |